Payment overview · 2025
General Payments
$369.99
6 reported records · 5 companies
Healthcare provider profile · identity verified
Ghulam Abbas, MD
Allopathic & Osteopathic Physicians|Internal Medicine · FREDERICK, MD · NPI 1477658045
Verified facts
What the public records show
CMS Open Payments records show Ghulam Abbas, MD received $369.99 in general payments during 2025 across 6 reported records.
INTUITIVE SURGICAL, INC. accounted for 49.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 133 claims for Myrbetriq by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 627 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $181.99 | 49.2% | 2 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $105.73 | 28.6% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $29.92 | 8.1% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $26.80 | 7.2% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $25.55 | 6.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $188.00 | 4 |
| Travel and Lodging | $181.99 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $181.99 | 2 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $105.73 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $29.92 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $26.80 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $25.55 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $25.55 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 627 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
133 | 18 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
627 | 75 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1324 | 162 |
| Furosemide | Furosemide | 1260 | 159 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1158 | 110 |
| Metoprolol Succinate | Metoprolol Succinate | 703 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 646 | 87 |
| Eliquis | Apixaban | 627 | 75 |
| Lisinopril | Lisinopril | 578 | 77 |
| Sertraline Hcl | Sertraline Hcl | 572 | 49 |
| Losartan Potassium | Losartan Potassium | 566 | 69 |
| Donepezil Hcl | Donepezil Hcl | 539 | 57 |
| Gabapentin | Gabapentin | 531 | 67 |
| Metoprolol Tartrate | Metoprolol Tartrate | 479 | 70 |
| Warfarin Sodium | Warfarin Sodium | 470 | 20 |
| Jardiance | Empagliflozin | 445 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 443 | 99 |
| Spironolactone | Spironolactone | 441 | 66 |
| Mirtazapine | Mirtazapine | 414 | 44 |
| Tramadol Hcl | Tramadol Hcl | 373 | 68 |
| Metformin Hcl | Metformin Hcl | 347 | 41 |
| Potassium Chloride | Potassium Chloride | 343 | 49 |
| Clopidogrel | Clopidogrel Bisulfate | 333 | 32 |
| Omeprazole | Omeprazole | 328 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 282 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 265 | 44 |
| Hydralazine Hcl | Hydralazine Hcl | 248 | 28 |
| Memantine Hcl | Memantine Hcl | 243 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 192 | 75 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 192 | suppressed |
| Allopurinol | Allopurinol | 186 | 26 |
| Buspirone Hcl | Buspirone Hcl | 183 | 20 |
| Prednisone | Prednisone | 182 | 49 |
| Carvedilol | Carvedilol | 177 | 26 |
| Oxycodone Hcl | Oxycodone Hcl | 176 | 37 |
| Amiodarone Hcl | Amiodarone Hcl | 175 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 171 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 157 | 16 |
| Lorazepam | Lorazepam | 157 | 47 |
| Montelukast Sodium | Montelukast Sodium | 157 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 152 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 149 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 143 | 14 |
| Trazodone Hcl | Trazodone Hcl | 143 | 23 |
| Levetiracetam | Levetiracetam | 135 | 13 |
| Myrbetriq | Mirabegron | 133 | 18 |
| Tresiba Flextouch U-100 | Insulin Degludec | 128 | 15 |
| Bupropion Xl | Bupropion Hcl | 121 | suppressed |
| Januvia | Sitagliptin Phosphate | 121 | 11 |
| Latanoprost | Latanoprost | 119 | 27 |
| Atenolol | Atenolol | 118 | suppressed |
| Novolog Flexpen | Insulin Aspart | 116 | 17 |
| Methenamine Hippurate | Methenamine Hippurate | 115 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 110 | 23 |
| Famotidine | Famotidine | 104 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 104 | 16 |
| Pregabalin | Pregabalin | 103 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 102 | 14 |
| Divalproex Sodium | Divalproex Sodium | 100 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 98 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 97 | 14 |
| Ondansetron Odt | Ondansetron | 97 | 25 |
| Loperamide | Loperamide Hcl | 96 | 31 |
| Humalog Kwikpen U-100 | Insulin Lispro | 92 | suppressed |
| Gemtesa | Vibegron | 86 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 84 | suppressed |
| Colchicine | Colchicine | 80 | suppressed |
| Lactulose | Lactulose | 79 | 25 |
| Finasteride | Finasteride | 76 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 72 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 70 | 12 |
| Zenpep | Lipase/Protease/Amylase | 68 | suppressed |
| Simvastatin | Simvastatin | 66 | 11 |
| Xarelto | Rivaroxaban | 65 | 12 |
| Colestipol Hcl | Colestipol Hcl | 64 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 63 | 39 |
| Nystatin | Nystatin | 61 | 24 |
| Methocarbamol | Methocarbamol | 59 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 57 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 54 | 29 |
| Morphine Sulfate | Morphine Sulfate | 54 | 18 |
| Felodipine Er | Felodipine | 53 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 53 | suppressed |
| Sucralfate | Sucralfate | 53 | 14 |
| Tresiba Flextouch U-200 | Insulin Degludec | 53 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 52 | suppressed |
| Torsemide | Torsemide | 51 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | 21 |
| Dicyclomine Hcl | Dicyclomine Hcl | 49 | suppressed |
| Meloxicam | Meloxicam | 49 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 49 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 48 | 34 |
| Bumetanide | Bumetanide | 48 | suppressed |
| Clonazepam | Clonazepam | 48 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 48 | 35 |
| Donepezil Hcl Odt | Donepezil Hcl | 47 | suppressed |
| Ozempic | Semaglutide | 47 | suppressed |
| Ezetimibe | Ezetimibe | 45 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 44 | suppressed |
| Cephalexin | Cephalexin | 44 | 28 |
| Ceftriaxone | Ceftriaxone Sodium | 43 | 21 |
| Memantine Hcl Er | Memantine Hcl | 43 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 42 | suppressed |
| Nifedipine Er | Nifedipine | 42 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 42 | 20 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 41 | 21 |
| Ursodiol | Ursodiol | 41 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 27 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | suppressed |
| Baclofen | Baclofen | 39 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 39 | suppressed |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 39 | suppressed |
| Levofloxacin | Levofloxacin | 39 | 30 |
| Metolazone | Metolazone | 39 | suppressed |
| Ketoconazole | Ketoconazole | 37 | 12 |
| Venlafaxine Hcl | Venlafaxine Hcl | 35 | suppressed |
| Azithromycin | Azithromycin | 34 | 17 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 34 | suppressed |
| Primidone | Primidone | 34 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 32 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 31 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 31 | suppressed |
| Linzess | Linaclotide | 31 | suppressed |
| Alprazolam | Alprazolam | 30 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 30 | 12 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 30 | 12 |
| Risperidone | Risperidone | 30 | suppressed |
| Entresto | Sacubitril/Valsartan | 29 | suppressed |
| Fluconazole | Fluconazole | 29 | 17 |
| Labetalol Hcl | Labetalol Hcl | 29 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 29 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Ranolazine Er | Ranolazine | 29 | suppressed |
| Phenytoin | Phenytoin | 28 | suppressed |
| Lacosamide | Lacosamide | 27 | suppressed |
| Lidocaine | Lidocaine | 27 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 11 |
| Tolterodine Tartrate | Tolterodine Tartrate | 27 | suppressed |
| Calcitriol | Calcitriol | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 14 |
| Ibuprofen | Ibuprofen | 26 | suppressed |
| Amoxicillin | Amoxicillin | 25 | 12 |
| Brilinta | Ticagrelor | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 25 | suppressed |
| Estradiol | Estradiol | 25 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 25 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 25 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 24 | suppressed |
| Clonidine | Clonidine | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Olanzapine | Olanzapine | 24 | suppressed |
| Anastrozole | Anastrozole | 23 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 23 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 23 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 22 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 22 | suppressed |
| Tetracycline Hcl | Tetracycline Hcl | 22 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 21 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 21 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 21 | suppressed |
| Restasis | Cyclosporine | 21 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Xtampza Er | Oxycodone Myristate | 21 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 20 | suppressed |
| Klayesta | Nystatin | 20 | 13 |
| Methimazole | Methimazole | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 16 |
| Albuterol Sulfate | Albuterol Sulfate | 19 | suppressed |
| Celecoxib | Celecoxib | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | 13 |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 19 | 11 |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 18 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 17 | 17 |
| Nyamyc | Nystatin | 17 | suppressed |
| Oxycontin | Oxycodone Hcl | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Aranesp | Darbepoetin Alfa In Polysorbat | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 16 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 14 | suppressed |
| Modafinil | Modafinil | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 13 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Silodosin | Silodosin | 13 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Loteprednol Etabonate | Loteprednol Etabonate | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Acetazolamide | Acetazolamide | 11 | suppressed |
| Admelog | Insulin Lispro | 11 | suppressed |
| Admelog Solostar | Insulin Lispro | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Linezolid | Linezolid | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Safetyglide Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $369.99 · 6 records | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System, ELIQUIS, FREESTYLE LIBRE 3, INSPIRE, NURTEC ODT, Veozah | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Astellas Pharma US Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error